BIOGEN INC.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 225 BINNEY STREET, CAMBRIDGE, MA, 02142
Mailing Address 225 BINNEY STREET, CAMBRIDGE, MA, 02142
Phone 7814642000
Fiscal Year End 1231
EIN 330112644
Financial Overview
FY2025
$1.63B
Net Income
$28.05B
Total Assets
$11.33B
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
Annual Reports
10-K February 6, 2026
- Strategic acquisitions of Reata Pharmaceuticals ($7.3B) and Human Immunology Biosciences (initial $1.8B) are diversifying Biogen's pipeline into rare diseases and immunology.
- Successful initial revenue generation from new drug launches including SKYCLARYS ($150M), QALSODY ($20M), and ZURZUVAE ($10M) in 2024.
Material Events
8-K Acquisition January 14, 2026
High Impact
- Strategic decision to invest in future growth by expanding their research pipeline.
- Active efforts to bring new treatments to market, potentially leading to new treatment options for patients.
Insider Trading
SELL 1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.